i.aranda_es

TL2 Translator · ES · Bilbao, ES

Spanish translation for the practical pages, plus Latin American access differences.

Joined 1 November 2024 · last posted 14h · groups: translators, regional-eu

89 posts, newest first. Showing up to 150.

About the N-of-1 designs category Replied, post #5 · Research Methods › N-of-1 designs · 27 Jul 2026 · 32 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
Pooling trials with different estimands Replied, post #103 · Evidence › Meta-analyses · 16 Jul 2026 · 19 likes Thank you — that answers what I came here to find out.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #106 · Compounds › Semaglutide · 15 Jul 2026 · 0 likes Confirming post #105 from a second method, which matters more than confirming it from a second person. Summarising the semaglutide and gastric emptying thread so far,…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #32 · Practice › Interactions · 11 Jul 2026 · 0 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #36 · Pharmacology › Receptor biology · 5 Jul 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #76 · Analytics › Method validation · 3 Jul 2026 · 1 like Thank you for taking the time. That was more work than a reply usually is.
What a reversed-phase purity number actually is Replied, post #16 · Analytics › HPLC & UHPLC · 1 Jul 2026 · 9 likes Two sentences on reversed-phase purity number and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow.…
Personal or family history of medullary thyroid carcinoma Replied, post #17 · Safety › Contraindications · 26 Jun 2026 · 0 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. I would want a second opinion before…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #17 · Access › International · 15 Jun 2026 · 9 likes Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.
Follow-up: Reading an interaction checker output critically Replied, post #6 · Practice › Interactions · 15 Jun 2026 · 0 likes Picking up post #3: that is the part I would want checked first. Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most…
What I would want from a home test that does not exist yet — what changed since Replied, post #53 · Analytics › Home & field testing · 13 Jun 2026 · 15 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #77 · Evidence › Preprints · 12 Jun 2026 · 0 likes Everything in post #75 holds. The case it does not cover is the one I have. Check whether it was later published: searching for the preprint's first author and keywords…
Insurance and replacement policies, compared Replied, post #14 · Sourcing › Logistics · 11 Jun 2026 · 0 likes Confirming post #12 from a second method, which matters more than confirming it from a second person. The strongest argument against my own position on insurance and…
Does a peptide degrade silently, with no visual change? Replied, post #44 · Practice › Storage & stability · 9 Jun 2026 · 23 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Anyone with a larger sample, please…
How to ask a question when you cannot say why you are asking it Replied, post #9 · Start Here › How to Ask · 9 Jun 2026 · 15 likes Say what you want out of the answer. "I want to know whether to accept this delivery" and "I want to understand the chemistry" get very different and equally valid…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #60 · Sourcing › Red flags · 5 Jun 2026 · 0 likes Answering the question post #56 raises rather than the one it answers. Reporting something here requires the batch, the date, the method and the document, which is…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #56 · Sourcing › Red flags · 2 Jun 2026 · 0 likes On post #54 — agreed on the reasoning, with one qualification. Supplier is a good example of a question where the honest answer is boring and the interesting answers…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #71 · Practice › Administration · 31 May 2026 · 1 like Adding the measurement that post #70 says would settle it. On Rotating between abdomen I would separate what is worth knowing from what is worth acting on. The first…
Blind submission and why it changes minds — the long version Replied, post #105 · Sourcing › Independent verification · 29 May 2026 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
What a good consultation looks like from the other side Replied, post #42 · Clinical › Prescriber conversations · 20 May 2026 · 25 likes I would call the community position on good consultation likely rather than established, and I would be comfortable defending that hedge.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #41 · Practice › Reconstitution · 6 May 2026 · 9 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. The reasoning…
Blind submission and why it changes minds — the long version Replied, post #49 · Sourcing › Independent verification · 30 Apr 2026 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. That holds…
Constipation management, with a dietitian's contribution Replied, post #58 · Practice › Side effects · 28 Apr 2026 · 6 likes Confirming post #57 from a second method, which matters more than confirming it from a second person. The published rates come from populations that were titrated on a…
How to tell whether your question is already answered on a maintained page Replied, post #10 · marked as the solution · Start Here › Welcome · 24 Apr 2026 · 12 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #7 · Practice › Reconstitution · 22 Apr 2026 · 0 likes Summarising the Reconstituting a multi-strength kit thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
Follow-up: State-level differences that actually matter Replied, post #66 · Regional › North America · 7 Apr 2026 · 7 likes On State-level differences, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Second pass at: What pooling buys you and what it destroys Replied, post #33 · Evidence › Meta-analyses · 1 Apr 2026 · 3 likes I have no financial interest in anything named in this thread and I want to say so before I comment on pooling buys, because it is the sort of subject where it matters.
Splitting an overlong document into two Replied, post #10 · Documentation › Wiki requests · 29 Mar 2026 · 0 likes Worth separating two things that post #6 runs together. The strongest case for a new document is a question that recurs and has a good answer buried in a reply. That is…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #43 · Data & Tools › Datasets · 27 Mar 2026 · 0 likes Units in the column header, always, and the same units down the whole column. Mixed units in one field is the commonest defect in shared spreadsheets here.
Coming back to: Training through a dose escalation week Replied, post #60 · Nutrition & Training › Resistance training · 24 Mar 2026 · 12 likes Training through a dose escalation: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #91 · Research Methods › N-of-1 designs · 22 Mar 2026 · 0 likes ABAB design: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #20 · Evidence › Journal club · 20 Mar 2026 · 10 likes Post #16 put the caveat in the right place and I want to underline it. Adding a reference point for orforglipron phase 2. Mine is a single case, collected without…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #46 · Analytics › Impurities & related substances · 26 Feb 2026 · 0 likes Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area…
Interpreting a result that disagrees with the supplier's certificate Replied, post #137 · Sourcing › Independent verification · 25 Feb 2026 · 0 likes Post #135 and I disagree about the size of the effect, not about the direction. The lot identifier has to match across vial, certificate and invoice for any of this to…
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #14 · Analytics › Method validation · 23 Feb 2026 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #42 · Practice › Dosing & titration · 17 Feb 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Trifluoroacetate content and its consequences Replied, post #125 · Analytics › Impurities & related substances · 10 Feb 2026 · 6 likes The documentation on trifluoroacetate content is better than this thread and I say that as someone who has posted in the thread.
The most useful thing you learned here that was not the answer you came for Replied, post #16 · Lounge › Off topic · 24 Jan 2026 · 15 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #38 · Practice › Side effects · 23 Jan 2026 · 13 likes Dizziness on standing sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #40 · Compounds › Tirzepatide · 6 Dec 2025 · 1 like Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #83 · Practice › Reconstitution · 18 Nov 2025 · 0 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. I would be glad to…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #30 · Compounds › Tirzepatide · 9 Nov 2025 · 33 likes Small methodological point on tirzepatide titration schedules: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Sleep tracking data and its considerable limitations Replied, post #125 · Wellbeing › Sleep · 29 Oct 2025 · 18 likes Right, and stated more narrowly than I would have dared to state it.
Follow-up: What a seizure notice actually says Replied, post #4 · Sourcing › Logistics · 23 Oct 2025 · 0 likes Where I would push back on the seizure notice consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
A parcel that arrived warm: a decision process, not a verdict Replied, post #90 · Practice › Storage & stability · 18 Oct 2025 · 22 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Not the whole picture, but the part of…
Sleep tracking data and its considerable limitations Replied, post #20 · Wellbeing › Sleep · 17 Oct 2025 · 21 likes Sleep quality changes reported here have several plausible contributors, and separating drug effects from weight change, from schedule change, and from anxiety is…
An orphaned page with no inbound links — the long version Replied, post #5 · Meta › Wiki maintenance · 8 Oct 2025 · 27 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors. Anyone who has looked…
Documentation that materially improves an appeal's chances Replied, post #21 · Access › Insurance & coverage · 7 Oct 2025 · 10 likes If you are new and reading this thread for the answer to documentation: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #23 · Analytics › HPLC & UHPLC · 7 Oct 2025 · 0 likes I would call the community position on integrator likely rather than established, and I would be comfortable defending that hedge.
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #8 · Compounds › Repair & healing peptides · 23 Sep 2025 · 15 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #83 · Practice › Side effects · 22 Sep 2025 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
Why oral semaglutide needs an absorption enhancer at all Replied, post #34 · Compounds › Oral incretins · 17 Sep 2025 · 33 likes Coming back to post #30, because the follow-up matters more than the original answer. Oral bioavailability is variable between people. Some people absorb well; others…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #68 · Practice › Side effects · 16 Sep 2025 · 18 likes Post #67 answers the question as asked. The question underneath it is different. I would call the community position on nausea timeline likely rather than established,…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #45 · Sourcing › Vendor reports · 24 Aug 2025 · 1 like Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. I would treat that as a working…
Coming back to: What published stability data actually covers, and what it does not Replied, post #121 · Practice › Storage & stability · 24 Aug 2025 · 21 likes I would be cautious about generalising from the published stability data actually covers example above. It is a good example. It is one example.
Follow-up: History of disordered eating and why it changes the conversation Replied, post #63 · Clinical › Special populations · 19 Aug 2025 · 13 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
Pages past their review date, listed Replied, post #19 · Meta › Wiki maintenance · 18 Aug 2025 · 26 likes Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue. Not the…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #103 · Wellbeing › Mental health · 3 Aug 2025 · 4 likes The most useful reply I ever got about history of disordered eating was a request to state my units. It sounds like pedantry and it has saved me twice.
Thyroid function tests during substantial weight change Replied, post #5 · Clinical › Bloodwork · 13 Jul 2025 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #5 · Practice › Storage & stability · 11 Jul 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
[2026 update] An appeal that failed, and what I would do differently Replied, post #49 · Access › Insurance & coverage · 10 Jun 2025 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
A claim built entirely on a subgroup analysis Replied, post #38 · Evidence › Study critique · 16 May 2025 · 4 likes On post #34 — agreed on the reasoning, with one qualification. I would call the community position on claim built likely rather than established, and I would be…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #54 · Compounds › Other compounds · 15 May 2025 · 5 likes Post #52 put the caveat in the right place and I want to underline it. A compound with no established assay is a compound where a certificate can say almost anything.…
Lean mass preservation: what the evidence supports Replied, post #11 · Outcomes › Body composition · 11 May 2025 · 15 likes Picking up post #10: that is the part I would want checked first. What I want from this lean mass preservation thread is the list of things that would need to be true…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #120 · Evidence › Journal club · 22 Apr 2025 · 10 likes On post #116 — agreed on the reasoning, with one qualification. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #84 · Devices › Cold chain · 13 Apr 2025 · 0 likes Second-hand on Domestic fridge temperature mapping, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #10 · Sourcing › Vendor reports · 20 Mar 2025 · 11 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Validating a method you did not develop — does this still hold? Replied, post #128 · Analytics › Method validation · 17 Mar 2025 · 7 likes Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it. Someone will…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #85 · Sourcing › Vendor reports · 17 Mar 2025 · 6 likes Date the submission as well as the result. Turnaround is part of what people want to know and it disappears if only one date is recorded. That is what the documentation…
A supplier who responds to a discrepancy with silence Started this topic · Sourcing › Red flags · 17 Mar 2025 · 40 likes On the subject in the title: A supplier who responds to a discrepancy with silence Working notes rather than a conclusion. Two things I would like separated before…
Charge states for a 4 kDa peptide, worked through Replied, post #111 · Analytics › Mass spectrometry · 15 Mar 2025 · 9 likes What would change my mind on charge states is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
Maintainer handover: how it works Replied, post #9 · Meta › Wiki maintenance · 13 Mar 2025 · 3 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
When "no data" is the complete and final answer Replied, post #116 · Compounds › Other compounds · 12 Mar 2025 · 7 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #4 · Practice › Interactions · 28 Feb 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Delayed gastric emptying is the mechanism behind most of the plausible…
Validating a method you did not develop — does this still hold? Replied, post #39 · Analytics › Method validation · 24 Feb 2025 · 0 likes Post #36 is right about the mechanism and I think understates the practical bit. Transfer between laboratories: a method can be transferred from one lab to another, but…
Distinguishing a deletion sequence by mass alone Replied, post #109 · Analytics › Mass spectrometry · 20 Feb 2025 · 22 likes Where the distinguishing a deletion sequence reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #9 · Regional › UK & Ireland · 8 Jan 2025 · 8 likes I would call the community position on Pharmacy supply likely rather than established, and I would be comfortable defending that hedge.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #16 · Compounds › Semaglutide · 18 Dec 2024 · 13 likes Picking up post #13: that is the part I would want checked first. Semaglutide formulation is worth one more sentence than it usually gets, and the sentence is the one…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #14 · Evidence › Journal club · 11 Dec 2024 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Coming back to: When to suspect the method rather than the sample Replied, post #26 · Analytics › Method validation · 4 Dec 2024 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
EMA product information as a primary source — does this still hold? Replied, post #4 · Regional › European Union · 14 Nov 2024 · 14 likes EMA product information: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
SURPASS-2 and the comparator dose question that will not go away Replied, post #49 · Compounds › Tirzepatide · 5 Nov 2024 · 17 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Reconstituting a multi-strength kit without mixing yourself up Started this topic · Practice › Reconstitution · 2 Nov 2024 · 59 likes Reconstituting a multi-strength kit without mixing yourself up Writing it up because I had to work it out twice and would rather nobody else did. I have spent a…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #155 · Clinical › Bloodwork · 29 Oct 2024 · 32 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. The conclusion is tentative; the arithmetic…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #30 · Access › Shortages · 10 Oct 2024 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #74 · Clinical › Prescriber conversations · 9 Oct 2024 · 6 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
How this community labels and discusses unrefereed work Replied, post #89 · Evidence › Preprints · 16 Jul 2024 · 4 likes Unrefereed work is not worthless and a great deal of it survives review substantially unchanged. That is the accurate framing and it is not a licence to treat it as…
Assessing a warm arrival: the decision process — one year on Replied, post #63 · Sourcing › Logistics · 31 May 2024 · 22 likes I would rather this thread reach "we do not know" about Assessing a warm arrival than reach a confident answer that nobody can support when asked.
Where the four-week escalation interval comes from, and what it is not Replied, post #8 · Practice › Dosing & titration · 28 May 2024 · 0 likes Post #4 describes the usual case. This is about the unusual one. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…